UFP Technologies Inc (UFPT) stock
UFPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 13/3023% above fair value
$297.49−1.05 (-0.35%)
Close on Nov 17, 2026Market cap $2.30BP/E 32.1Yield –
UFP Technologies r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $8.60M, down 17.3% from the year before. Over ten years it grew 20.8% a year on average. The highest annual figure on record is $10.50M in fiscal 2018.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.60M | -17.3% |
| FY2024 | Dec 31, 2024 | $10.40M | +44.4% |
| FY2023 | Dec 31, 2023 | $7.20M | -22.6% |
| FY2022 | Dec 31, 2022 | $9.30M | +9.4% |
| FY2021 | Dec 31, 2021 | $8.50M | +3.7% |
| FY2020 | Dec 31, 2020 | $8.20M | -6.8% |
| FY2019 | Dec 31, 2019 | $8.80M | -16.2% |
| FY2018 | Dec 31, 2018 | $10.50M | +110.0% |
| FY2017 | Dec 31, 2017 | $5.00M | +284.6% |
| FY2016 | Dec 31, 2016 | $1.30M | 0.0% |
| FY2015 | Dec 31, 2015 | $1.30M | -7.1% |
| FY2014 | Dec 31, 2014 | $1.40M | +16.7% |
| FY2013 | Dec 31, 2013 | $1.20M | -7.7% |
| FY2012 | Dec 31, 2012 | $1.30M | +8.3% |
| FY2011 | Dec 31, 2011 | $1.20M | +33.3% |
| FY2010 | Dec 31, 2010 | $900.00K | – |
See a number that looks wrong?